Eyevensys is a clinical stage, private, biotechnology company developing its innovative EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic disease.

Biotechnology

Eyevensys

Patricia Zilliox

Alan Wirbisky

Gina Pinto

Francine Behar-Cohen

Joshua L. Dunaief

Frederick L. Ferris III

Mark Pennesi

Peter K. Kaiser

Leonard Levin

Dominick Escher

Sunil K. Srivastava

Joon Hyun

Thomas Hohman

Dani Bach

The Advisors team at Eyevensys provides strategic guidance and expert insights to support the development and commercialization of the EyeCET platform. Leveraging their extensive experience in biotechnology and ophthalmology, they help shape the company's direction, ensure regulatory compliance, and foster partnerships within the industry.

Advisors

This department focuses on strategic oversight and high-level management.

Leadership Circle

This department oversees the development of devices and manages financial and administrative functions.

Device Development and Finance

The Leadership Team at Eyevensys is responsible for guiding the strategic direction and overall vision of the company as it develops its EyeCET platform. This team, composed of key executives with expertise in innovation, science, and business management, collaborates to drive research and development initiatives, secure funding, and establish partnerships, ensuring the successful advancement of novel therapies for ophthalmic diseases.

Leadership Team

Eyevensys

Org chart

Board & advisors

Teams

Advisors

Leadership Circle

Device Development and Finance

Leadership Team

Offices

Eyevensys

Org chart

Board & advisors

Teams

Advisors

Leadership Circle

Device Development and Finance

Leadership Team

Offices

Related companies